Using Cyclica’s technology to identify repurposed drug candidates for COVID-19

At the time of writing this article, over 1.3 million people have been confirmed to be infected...

CONTINUE READING

Part I: Leadership Lessons: Leading During Uncertainty (a COVID19 motivated article)

Originally published on LinkedIn: https://bit.ly/3BnnNzB

Reflecting on the past four months, many...

CONTINUE READING

Discarding information to make predictions: Thoughts on how to predict drug properties robustly

CONTINUE READING

The Stories of the Phenomenal Women of Cyclica

The Science, Technology, Engineering, and Math (STEM) disciplines are responsible for many...

CONTINUE READING

The Future of Healthcare in Africa: Opportunities for Ecosystem Driven Innovation with AI

Originally posted on LinkedIn: https://bit.ly/3mqQrM7

The purpose of this post is to: i) highlight...

CONTINUE READING

What's the fuss behind polypharmacology & multi-targeted drug design?

Originally posted on LinkedIn: https://bit.ly/3bpyKpG

It is well understood that while the common...

CONTINUE READING

Part II - Facing Failure Head On: What Our Startup Learned From One of Our Biggest Mistakes - Branding

Originally posted on LinkedIn: https://bit.ly/3CubQtp

I am not sure where I heard it first - I...

CONTINUE READING

When Is A.I. Trustworthy? When Is A.I. Useful?

This post was adapted from its original source on OneZero and can be viewedhere.

When we talk about...

CONTINUE READING

Predicting Drug Target Interactions: Advances and Pitfalls

 

CONTINUE READING

Facing Failure Head On: What Our Startup Learned From One of Our Biggest Mistakes

Originally posted on LinkedIn: https://bit.ly/3jNLr2r

I’ll admit, I’ve recently felt an imbalance...

CONTINUE READING